EAST-LC: Randomized controlled phase III trial of S-1 versus docetaxel (DOC) in patients with non-small cell lung cancer (NSCLC) who had received a platinum-based treatment: Results from patient-reported outcomes (PROs)
Year: 2017
Type: article
Source: Annals of Oncology
Institutions: National University Hospital, National University Health System, Chinese University of Hong Kong, Chinese Academy of Medical Sciences & Peking Union Medical College, Sun Yat-sen University, Sun Yat-sen University Cancer Center, Shanghai Jiao Tong University, Shanghai Chest Hospital, National Taiwan University Hospital, Kindai University, Wakayama Medical University, National Cancer Center Hospital, Sendai Kousei Hospital, The Cancer Institute Hospital, Japanese Foundation For Cancer Research, Shizuoka Cancer Center, National Cancer Center Hospital East, Fudan University, Fudan University Shanghai Cancer Center, Miyagi Prefectural Hospital Organization, National Hospital Organization Kyushu Cancer Center, Jilin Province Tumor Hospital, National Cancer Centre Singapore, Kyoto University, St. Luke's International Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2770773767